Effect of intraperitoneal bupivacaine on pain relief after laparoscopic cholecystectomy

Study the effect of intraperitoneal bupivacaine on patient's pain relief after laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138810112946N1

Enrollment

Registered

2010-05-25

Start date

2009-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

local anesthesia. Drugs, medicaments and biological substances causing adverse effects in therapeutic use

Interventions

control group recieved nothing

Intervention 1: injecting 20cc bupivacaine in to diaphragm cavity in intervention group. Intervention 2: control group recieved nothing.

Treatment - Drugs

injecting 20cc bupivacaine in to diaphragm cavity in intervention group

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA I, II patients who underwent laparoscopic cholecystectomy. Exclusion criteria: patients with history of Diabetes, acute cholecystitis, heart ischemia, former bile ducts surgeries, addiction and sensitivity to local anesthesia drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Patient pain severity. Timepoint: every 1 hour for 4 hours after transfering to the ward. Method of measurement: VAS.	—

Secondary

Measure	Time frame
Patient's nausa severity. Timepoint: every 1 hour during first 4 hours after transferring to the ward. Method of measurement: VAS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mitra Yari

Kermanshah university of medical sciences

myari@kums.ac.ir+98 83 1428 2670

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026